Tirzepatide is a dual GIP and GLP-1 receptor agonist used in approved medicines for specific metabolic indications, including type 2 diabetes and chronic weight management.

The Sixpex listing identifies a 10 mg strength, but the supplied information does not establish its dosage form, package quantity, or relationship to an approved medicinal product.

Professional prescribing and monitoring are important with tirzepatide. GORoids should verify the product label, storage requirements, manufacturer information, and regulatory status before publication.